* | Non-spacer group (8 patients) | Spacer group (15 patients) | P value |
---|---|---|---|
Prostate volume (cc) | 66.48 ± 22.07 (41.30–109.35) | 57.57 ± 20.78 (25.73–95.96) | 0.333 |
Rectal volume (cc) | 191.7 ± 30.9 (154.9–231.1) | 172.8 ± 23.1 (135.2–206.9) | 0.131 |
Rectum Dmax | 74.15 ± 0.87 (73.00–76.0) | 73.15 ± 0.89 (71.02–74.0) | 0.013 |
Rectum Dmean | 24.10 ± 7.56 (12.66–36.39) | 19.1 ± 4.6 (9.73–25.75) | 0.065 |
Rectum Dmedian | 13.44 ± 11.88 (2.13–38.41) | 7.4 ± 5.02 (1.6–18.59) | 0.238 |
RV73Gy | 0.67 ± 0.58 (0.05–1.53) | 0.12 ± 0.13 (0–0.42) | 0.007 |
RV72Gy | 3.34 ± 1.89 (1.12–6.66) | 1.19 ± 1.0 (0.00–3.04) | 0.005 |
RV70Gy | 7.56 ± 2.97 (2.45–10.72) | 3.078 ± 2.23 (0.05–6.87) | 0.001 |
RV68.4 Gy (95% of dose) | 9.52 ± 3.41 (3.32–12.64) | 4.17 ± 2.71 (0.15–8.8) | 0.002 |
RV66Gy | 11.95 ± 4.27 (4.27–15.83) | 5.67 ± 3.31 (0.37–10.86) | 0.003 |
RV65Gy | 12.90 ± 4.57 (4.93–17.69) | 6.25 ± 3.52 (0.51–11.63) | 0.003 |
RV62Gy | 15.51 ± 5.86 (5.76–3.25) | 8.1 ± 4.18 (1.05–14.08) | 0.005 |
RV60Gy | 17.11 ± 6.12 (6.46–26.75) | 9.49 ± 4.32 (1.82–15.40) | 0.005 |
RV55Gy | 20.95 ± 8.1 (7.95–33.46) | 13.22 ± 4.74 (3.12–18.74) | 0.016 |
RV50Gy | 24.18 ± 9.20 (9.6–38.92) | 16.49 ± 5.38 (4.57–22.76) | 0.019 |
RV40Gy | 29.96 ± 11.1 (12.97–48.65) | 22.15 ± 6.48 (8.26–32.02) | 0.056 |
RV30Gy | 35.49 ± 12.51 (16.84–56.85) | 27.91 ± 7.49 (12.61–40.32) | 0.065 |
RV20Gy | 41.75 ± 13.72 (21.62–64.97) | 34.48 ± 8.39 (18.25–48.8) | 0.149 |
RV10Gy | 50.42 ± 14.65 (29.74–74.97) | 43.85 ± 9.44 (26.67–59.37) | 0.231 |